News Conference News HFSA 2022 No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3 Yael L. Maxwell October 07, 2022
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Daily News Dobutamine Shortage: ACC Experts Offer Tips, Alternatives Shelley Wood August 11, 2022
News Daily News Black and Hispanic Patients Not Accessing High-Volume TEER Centers Michael O'Riordan July 19, 2022
News Daily News Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’ Michael O'Riordan July 18, 2022
News Conference News TVT 2022 Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry Michael O'Riordan June 13, 2022
News Conference News TVT 2022 Surgical Explant or Redo for TAVI Failures? Some Registry Insights Michael O'Riordan June 10, 2022
News Conference News TVT 2022 No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest Michael O'Riordan June 09, 2022
News Conference News TVT 2022 Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests Michael O'Riordan June 09, 2022
News Conference News EuroPCR 2022 MitraClip Helps for Atrial Functional MR: MITRA-TUNE Michael O'Riordan May 19, 2022
News Daily News Medtronic Recalls Harmony Delivery Catheters Due to Breakage Risk L.A. McKeown April 26, 2022
News Conference News ACC 2022 ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI Todd Neale April 05, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022